Primary |
Glaucoma |
44.4% |
Ocular Hypertension |
33.3% |
Open Angle Glaucoma |
22.2% |
|
Death |
50.0% |
Cataract Operation |
7.1% |
Myasthenia Gravis Crisis |
7.1% |
Pulmonary Embolism |
7.1% |
Renal Cancer Metastatic |
7.1% |
Retinal Detachment |
7.1% |
Urinary Tract Infection |
7.1% |
Visual Acuity Reduced |
7.1% |
|
Secondary |
Intraocular Pressure Increased |
29.6% |
Ill-defined Disorder |
14.8% |
Glaucoma |
11.1% |
Chest Pain |
4.9% |
Musculoskeletal Pain |
4.9% |
Pain |
4.9% |
Pain In Extremity |
4.9% |
Sleep Disorder |
4.9% |
Blood Cholesterol Increased |
3.7% |
Discomfort |
3.7% |
Hypertension |
3.7% |
Inflammation |
3.7% |
Abnormal Dreams |
1.2% |
Blood Cholesterol Abnormal |
1.2% |
Blood Pressure Abnormal |
1.2% |
Open Angle Glaucoma |
1.2% |
|
Tinnitus |
40.0% |
Pruritus |
13.3% |
Discomfort |
6.7% |
Drug Hypersensitivity |
6.7% |
Drug Ineffective |
6.7% |
Headache |
6.7% |
Pain |
6.7% |
Urinary Tract Infection |
6.7% |
Visual Impairment |
6.7% |
|
Concomitant |
Product Used For Unknown Indication |
28.9% |
Glaucoma |
19.3% |
Drug Use For Unknown Indication |
10.2% |
Hypertension |
7.6% |
Blood Cholesterol Increased |
3.5% |
Osteoporosis |
3.5% |
Gastrooesophageal Reflux Disease |
2.9% |
Non-small Cell Lung Cancer |
2.9% |
Diabetes Mellitus |
2.3% |
Pain |
2.3% |
Anxiety |
2.0% |
Chronic Obstructive Pulmonary Disease |
2.0% |
Intraocular Pressure Increased |
2.0% |
Bone Disorder |
1.8% |
Plasma Cell Myeloma |
1.8% |
Eye Disorder |
1.5% |
Prostate Cancer |
1.5% |
Thyroid Disorder |
1.5% |
Arthralgia |
1.2% |
Asthma |
1.2% |
|
Vomiting |
12.5% |
Fall |
7.1% |
Urticaria |
7.1% |
Weight Decreased |
7.1% |
Dehydration |
5.4% |
Intraocular Pressure Increased |
5.4% |
Myocardial Infarction |
5.4% |
Rash Pruritic |
5.4% |
Vision Blurred |
5.4% |
Death |
3.6% |
Dizziness |
3.6% |
Dyspnoea |
3.6% |
Eye Irritation |
3.6% |
Fistula |
3.6% |
Glucose Tolerance Impaired |
3.6% |
Hepatic Enzyme Increased |
3.6% |
Insomnia |
3.6% |
Ischaemic Stroke |
3.6% |
Metastases To Bone |
3.6% |
Nausea |
3.6% |
|